NEW YORK (GenomeWeb News) – VWR International today announced the acquisition of Amresco for an undisclosed amount.
Based in Solon, Ohio, Amresco manufactures and supplies biochemicals and reagents for use in research in the molecular biology, life sciences, proteomics, clinical, and histology markets.
The addition of Amresco expands VWR's product portfolio, Matt Malenfant, VWR senior vice president and president of North America, Lab Business and Services, said in a statement. He added that Amresco's "expertise plays well with our increased focus on chemical and life science applications and will provide our customers greater choice and value."
VWR is a global laboratory supply and distribution firm based in Radnor, Penn. It generated worldwide sales of $3.5 billion in 2009.